$FMS - A High-Conviction Value Play with Executed TurnoverSynthesized Investment Thesis for Fresenius Medical Care (FMS): A High-Conviction Value Play with Executed Turnover
Fresenius Medical Care (FMS) presents a compelling case as a deep-value, contrarian investment for the long-term investor. The thesis hinges on its irreplaceable market position in a n
Fresenius Medical Care AG
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.88 USD
556.86 M USD
20.02 B USD
198.23 M
About Fresenius Medical Care AG
Sector
Industry
CEO
Helen Giza
Website
Headquarters
Bad Homburg
Founded
2006
IPO date
Oct 2, 1996
Identifiers
2
ISIN DE0005785802
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.
Related stocks
ABC/DTarget is D.
Possible stop under C.
I own this and it is a slow but a steady mover.
I scooped this up very close to the bottom and have not been disappointed.
Not yet anyway LOL.
The market has a way of biting me when I least expect it but I plan to hang.
No recommendation.
ATH 57.94
EARNINGS 8-2/
Cup and HandleResistance overhead from a prior gap down. OVERBOUGHT using standard RSI set at 70.
Cup low is 12.79.
Earnings 5-9-23.
This company is in Germany and provides dialysis to kidney failure patients. There are clinics al over the US owned by this company providing a service that kidney failure pati
Bottom FishingAscending Triangle.
ATL is 3.35.
3 year low is 12.79 which was made recently.
ATH 57.94.
Another dialysis company that is not based in the USA, so as a rule there would be no dividend.
Dialysis is not going away unfortunately and these dialysis sessions 3 times a week will always be covered as far
FMC Trade with MOUNT Germany 30 Quant SystemTrading is Waiting - Quants have a lot of time and wait until they the setup fits their requirements.
Traderama uses quant based "buy the valley" strategies for equity trading. This is an example, that the best returns will be achieved if you find the bottom and trade the bounce.
This trade example
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
F
FMS5184425
Fresenius Medical Care US Finance III, Inc. 3.0% 01-DEC-2031Yield to maturity
4.84%
Maturity date
Dec 1, 2031
F
USU3149FAB5
Fresenius Medical Care US Finance III, Inc. 2.375% 16-FEB-2031Yield to maturity
4.74%
Maturity date
Feb 16, 2031
F
US35805BAA61
Fresenius Medical Care US Finance III, Inc. 3.75% 15-JUN-2029Yield to maturity
4.26%
Maturity date
Jun 15, 2029
F
USU3149FAA76
Fresenius Medical Care US Finance III, Inc. 3.75% 15-JUN-2029Yield to maturity
4.26%
Maturity date
Jun 15, 2029
F
FMS5184423
Fresenius Medical Care US Finance III, Inc. 1.875% 01-DEC-2026Yield to maturity
4.18%
Maturity date
Dec 1, 2026
XS303664777
Fresenius Medical Care AG 3.75% 08-APR-2032Yield to maturity
3.37%
Maturity date
Apr 8, 2032
XS323349908
Fresenius Medical Care AG 3.25% 24-NOV-2030Yield to maturity
3.18%
Maturity date
Nov 24, 2030
XS2084488209
Fresenius Medical Care AG 1.25% 29-NOV-2029Yield to maturity
2.83%
Maturity date
Nov 29, 2029
XS303664769
Fresenius Medical Care AG 3.125% 08-DEC-2028Yield to maturity
2.70%
Maturity date
Dec 8, 2028
XS253044462
Fresenius Medical Care AG 3.875% 20-SEP-2027Yield to maturity
2.59%
Maturity date
Sep 20, 2027
See all FMCQF bonds
Frequently Asked Questions
The current price of FMCQF is 45.00 USD — it has decreased by −2.97% in the past 24 hours. Watch Fresenius Medical Care AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Fresenius Medical Care AG stocks are traded under the ticker FMCQF.
We've gathered analysts' opinions on Fresenius Medical Care AG future price: according to them, FMCQF price has a max estimate of 73.24 USD and a min estimate of 37.80 USD. Watch FMCQF chart and read a more detailed Fresenius Medical Care AG stock forecast: see what analysts think of Fresenius Medical Care AG and suggest that you do with its stocks.
FMCQF reached its all-time high on Apr 16, 2007 with the price of 151.78 USD, and its all-time low was 26.55 USD and was reached on Sep 27, 2022. View more price dynamics on FMCQF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FMCQF stock is 3.06% volatile and has beta coefficient of 0.46. Track Fresenius Medical Care AG stock price on the chart and check out the list of the most volatile stocks — is Fresenius Medical Care AG there?
Today Fresenius Medical Care AG has the market capitalization of 14.10 B, it has decreased by −2.86% over the last week.
Yes, you can track Fresenius Medical Care AG financials in yearly and quarterly reports right on TradingView.
Fresenius Medical Care AG is going to release the next earnings report on Feb 24, 2026. Keep track of upcoming events with our Earnings Calendar.
FMCQF earnings for the last quarter are 1.29 USD per share, whereas the estimation was 1.22 USD resulting in a 5.56% surprise. The estimated earnings for the next quarter are 1.33 USD per share. See more details about Fresenius Medical Care AG earnings.
Fresenius Medical Care AG revenue for the last quarter amounts to 5.73 B USD, despite the estimated figure of 5.78 B USD. In the next quarter, revenue is expected to reach 5.66 B USD.
FMCQF net income for the last quarter is 322.46 M USD, while the quarter before that showed 265.37 M USD of net income which accounts for 21.51% change. Track more Fresenius Medical Care AG financial stats to get the full picture.
Yes, FMCQF dividends are paid annually. The last dividend per share was 1.64 USD. As of today, Dividend Yield (TTM)% is 3.51%. Tracking Fresenius Medical Care AG dividends might help you take more informed decisions.
Fresenius Medical Care AG dividend yield was 3.26% in 2024, and payout ratio reached 78.55%. The year before the numbers were 3.13% and 69.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 113.84 K employees. See our rating of the largest employees — is Fresenius Medical Care AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fresenius Medical Care AG EBITDA is 3.92 B USD, and current EBITDA margin is 16.44%. See more stats in Fresenius Medical Care AG financial statements.
Like other stocks, FMCQF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fresenius Medical Care AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Fresenius Medical Care AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Fresenius Medical Care AG stock shows the sell signal. See more of Fresenius Medical Care AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









